Resveratrol Identified as an Anti-Cancer Compound
Antiproliferation
The authors reviewed studies examining resveratrol's ability to suppress proliferation of a wide variety of tumor cells, including lymphoid and myeloid cancers; cancers of the breast, colon, pancreas, stomach, prostate, head and neck, ovary, liver, lung and cervical cancers; melanoma; and muscles. Some studies indicate antiproliferative effects at certain dose ranges but not others, indicating further need for systemic research to test a range of resveratrol concentrations in vitro and then apply those doses in vivo to the different types of tumors.
Apoptosis
Besides inhibiting proliferation, resveratrol was also shown to induce apoptosis through one of two pathways (inducing Fas-dependent apoptosis in some cell lines, and Fas-independent apoptosis in others) in b-cell and t-cell lymphomas; myeloid leukemia; breast, colon, pancreas, stomach, prostate, thyroid and head and neck, ovary, liver, lung, and cervical cancers; and melanoma. Most studies indicate resveratrol does not induce apoptosis in normal cells.
In vitro and animal studies comprised the majority of the research reviewed, though several of the leukemia studies were in vivo. The research points to anti-inflammatory and antioxidant effects of resveratrol as well. Good sources of resveratrol include grapes, peanuts, cranberries and other berries.
The researchers conclude that resveratrol holds great potential in cancer prevention and therapy. In vivo studies clearly showed that resveratrol is pharmacologically safe. Its ability to radiosensitive and chemosensitize suggest additional opportunities. With a simple structure and the presence of hydroxyl groups, resveratrol would also be well suited for structure-activity relationship studies to improve biopotency and bioavailability.
Reference: Aggarwal, BB. Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies. Anticancer Research 2004;24:2783-2840.
Health Headlines
upcoming Events
U.S. Events
congresses
fellowships
-
Aesthetic Medicine Module I
Las Vegas, NV | Dec. 9-10, 2009 -
Anti-Aging & Regenerative Medicine Modules I, II, III & IX
Las Vegas, NV | Dec. 10-12, 2009 -
Preventative Medicine, Nutrition & Sports Medicine Module I
Las Vegas, NV | Dec. 9-11, 2009 -
Fellowship in Preventative Medicine, Nutrition & Sports Medicine Module III
Las Vegas, NV | Dec. 11-12, 2009
symposium
-
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health
(PATH Medical), Chairs the
Brain Age Workshop taking place Dec. 9, 2009.
Held in conjunction with the Winter Session of the 17th Annual World
Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies.
The Brain Age Workshop features presentations on Brain Mind Assessment
via Neuropsychological Analysis, Movement Deficiency Syndrome,
Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain
Injury. View this video to learn about Dr. Braverman’s brain-based
model of aging and age modulation.
International Events
- Mexico City | Jan. 15-17, 2010
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Jakarta | May 2010 (pending)
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Dubai | Oct. 26-27, 2010
- Bali | October 2010 (pending)
- Mainz-Frankfurt | Nov. 8-10, 2010
- Sao Paulo | Nov. 12-14, 2010
- Shanghai | November 2010 (pending)





